Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Sinovac Biotech (北京科兴生物制品有限公司)...
Boehringer Ingelheim will invest $149 million in China...
Sinovac Biotech has received a very large order for 5.2...
Sinovac Biotech Ltd. will move the home for its stock...
Novartis made a five-year, $1 billion China commitment,...
Sinovac Biotech Ltd....
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
Sinovac Biotech (北京科兴生物制品有限公司)...
Merck Serono will build a $250 million global R&D center...
Sinovac Biotech Ltd....
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China